Johnson & Johnson - Company Profile
Powered by
All the data and insights you need on Johnson & Johnson in one report.
- Save hours of research time and resources with
our up-to-date Johnson & Johnson Strategy Report
- Understand Johnson & Johnson position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products and medical devices. The company conducts business through its operating companies. It provides pharmaceuticals for immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopaedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, healthcare professionals and hospitals. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US) and Latin America. J&J is headquartered in New Brunswick, New Jersey, the US.
Johnson & Johnson premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Pharmaceutical | - |
Immunology: | Johnson’s |
Rheumatoid Arthritis | Listerine |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In April, the company signed a deal to acquire Shockwave Medical for US$13.1 billion. |
2024 | Regulatory Approval | In April, the company secured approval from the U.S. Food and Drug Administration for CARVYKTI to treat myeloma. |
2024 | Contracts/Agreements | In April, the company announced a collaboration with 100 community-led organizations to promote health equity. |
Competitor Comparison
Key Parameters | Johnson & Johnson | F. Hoffmann-La Roche Ltd | Merck & Co Inc | Pfizer Inc | Sanofi |
---|---|---|---|---|---|
Headquarters | United States of America | Switzerland | United States of America | United States of America | France |
City | New Brunswick | Basel | Kenilworth | New York | Paris |
State/Province | New Jersey | - | New Jersey | New York | Ile-de-France |
No. of Employees | 131,900 | 103,605 | 72,000 | 88,000 | 87,994 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Joaquin Duato | Chief Executive Officer; Chairman | Executive Board | 2023 | 61 |
Joseph J. Wolk | Chief Financial Officer; Executive Vice President | Senior Management | 2018 | 57 |
James Swanson | Executive Vice President; Chief Information Officer | Senior Management | 2022 | 58 |
Peter M. Fasolo, Ph.D. | Chief Human Resources Officer; Executive Vice President | Senior Management | 2016 | 61 |
William N. Hait, M.D., Ph. D. | Chief External Innovation and Medical Safety Officer; Executive Vice President | Senior Management | 2022 | 74 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward